---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-038936"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:28:02.659965+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq letter on Nov 13, 2023 for non-compliance with minimum $1.00 bid price rule.
- Common stock closing bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until May 13, 2024, to regain compliance.
- If not compliant by deadline, may request additional 180 days if other listing standards are met.
- Considering potential reverse stock split to cure deficiency.

## SEC filing metadata
- accession: 0001628280-23-038936
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/0001628280-23-038936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/xfor-20231113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-038936
- JSON: https://secwatch.observer/filing/0001628280-23-038936.json
- Plain text: https://secwatch.observer/filing/0001628280-23-038936.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.